266 related articles for article (PubMed ID: 3172094)
1. Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis-dermatomyositis.
Oddis CV; Medsger TA
J Rheumatol; 1988; 15(5):807-11. PubMed ID: 3172094
[TBL] [Abstract][Full Text] [Related]
2. Polymyositis/dermatomyositis: clinical features and outcome in 22 patients.
Baron M; Small P
J Rheumatol; 1985 Apr; 12(2):283-6. PubMed ID: 3875720
[TBL] [Abstract][Full Text] [Related]
3. Clinical and serologic features of patients with polymyositis or dermatomyositis.
Holden DJ; Brownell AK; Fritzler MJ
Can Med Assoc J; 1985 Mar; 132(6):649-53. PubMed ID: 3872156
[TBL] [Abstract][Full Text] [Related]
4. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
[TBL] [Abstract][Full Text] [Related]
5. Rituximab as therapy for refractory polymyositis and dermatomyositis.
Noss EH; Hausner-Sypek DL; Weinblatt ME
J Rheumatol; 2006 May; 33(5):1021-6. PubMed ID: 16541475
[TBL] [Abstract][Full Text] [Related]
6. Influence of age at onset on the duration of treatment in idiopathic adult polymyositis and dermatomyositis.
McKendry RJ
Arch Intern Med; 1987 Nov; 147(11):1989-91. PubMed ID: 3675101
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
[TBL] [Abstract][Full Text] [Related]
8. Strength in polymyositis and dermatomyositis: best outcome in patients treated early.
Fafalak RG; Peterson MG; Kagen LJ
J Rheumatol; 1994 Apr; 21(4):643-8. PubMed ID: 8035387
[TBL] [Abstract][Full Text] [Related]
9. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE
Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive use of hydroxychloroquine in childhood dermatomyositis.
Olson NY; Lindsley CB
J Rheumatol; 1989 Dec; 16(12):1545-7. PubMed ID: 2483176
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review.
Qushmaq KA; Chalmers A; Esdaile JM
J Rheumatol; 2000 Dec; 27(12):2855-9. PubMed ID: 11128676
[TBL] [Abstract][Full Text] [Related]
12. [Clinico-developmental aspects in 44 cases of polymyositis/dermatomyositis].
Bravaccio F; Tirri R; Ammendola A; Picillo U; Cantore R; Trabucco M; Tirri G
Acta Neurol (Napoli); 1989; 11(2-3):102-16. PubMed ID: 2782112
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids.
Ramanan AV; Campbell-Webster N; Ota S; Parker S; Tran D; Tyrrell PN; Cameron B; Spiegel L; Schneider R; Laxer RM; Silverman ED; Feldman BM
Arthritis Rheum; 2005 Nov; 52(11):3570-8. PubMed ID: 16255046
[TBL] [Abstract][Full Text] [Related]
14. Muscle strength assessment in polymyositis and dermatomyositis evaluation of the reliability and clinical use of a new, quantitative, easily applicable method.
Stoll T; Brühlmann P; Stucki G; Seifert B; Michel BA
J Rheumatol; 1995 Mar; 22(3):473-7. PubMed ID: 7783064
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis].
Tong SQ; Shi XH; Su JM; Zhao Y; Zhang FC
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):624-7. PubMed ID: 16681909
[TBL] [Abstract][Full Text] [Related]
16. Serum muscle enzymes, muscle pathology and clinical muscle weakness: correlation in Thai patients with polymyositis/dermatomyositis.
Louthrenoo W; Weerayutwattana N; Lertprasertsuke N; Sukitawut W
J Med Assoc Thai; 2002 Jan; 85(1):26-32. PubMed ID: 12075717
[TBL] [Abstract][Full Text] [Related]
17. Polymyositis-dermatomyositis:25 years of follow-up of 50 patients disease course, treatment, prognostic factors.
Chwalińska-Sadowska H; Małdykowa H
Mater Med Pol; 1990; 22(3):213-8. PubMed ID: 2132429
[TBL] [Abstract][Full Text] [Related]
18. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis.
Miller FW; Leitman SF; Cronin ME; Hicks JE; Leff RL; Wesley R; Fraser DD; Dalakas M; Plotz PH
N Engl J Med; 1992 May; 326(21):1380-4. PubMed ID: 1472183
[TBL] [Abstract][Full Text] [Related]
19. Muscular strength as an index of response to therapy in childhood dermatomyositis.
Resnick JS; Mammel M; Mundale MO; Kottke FJ
Arch Phys Med Rehabil; 1981 Jan; 62(1):12-9. PubMed ID: 7458626
[TBL] [Abstract][Full Text] [Related]
20. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.
Marie I; Hachulla E; Hatron PY; Hellot MF; Levesque H; Devulder B; Courtois H
J Rheumatol; 2001 Oct; 28(10):2230-7. PubMed ID: 11669162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
